Champions Oncology, Inc. (CSBR)

Champions Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Net Income	2.92	4.7	-7.28	-5.34	0.55	0.36
Depreciation & Amortization	1.55	1.64	1.87	2.25	1.63	1.18
Stock-Based Compensation	0.6	0.65	1.12	0.86	0.91	0.6
Other Adjustments	0.96	1.01	1.98	1.95	1.07	0.37
Change in Receivables	-0.24	-1.44	-1.99	1.31	-2.82	-2.27
Changes in Accounts Payable	-0.77	-1.75	0.47	2.47	0.97	-1.25
Changes in Accrued Expenses	-0.3	0.4	-0.11	-0.15	0.18	-0.32
Changes in Unearned Revenue	4.12	3.35	-0.68	1.71	4.82	0.44
Changes in Other Operating Activities	-1.3	-1.18	-1.51	-1.09	-0.82	-0.81
Operating Cash Flow	7.68	7.39	-6.14	3.97	6.5	-1.68
Operating Cash Flow Growth	-	-	-	-38.86%	-	-
Capital Expenditures	-0.44	-0.39	-0.84	-2.87	-2.38	-3.28
Other Investing Activities	-	-	-	-	-	0.11
Investing Cash Flow	-0.44	-0.39	-0.84	-2.87	-2.38	-3.17
Long-Term Debt Repaid	-0.15	-0.15	-0.15	-	-	-0.17
Net Long-Term Debt Issued (Repaid)	-0.15	-0.15	-0.15	-	-	-0.17
Issuance of Common Stock	-	0.32	0.25	0.09	0.21	1.37
Repurchase of Common Stock	-	-	-0.63	-0.07	-	-
Net Common Stock Issued (Repurchased)	-	0.32	-0.38	0.01	0.21	1.37
Financing Cash Flow	-0.15	0.17	-0.53	0.01	0.21	1.2
Net Cash Flow	7.43	7.17	-7.5	1.11	4.32	-3.66
Beginning Cash & Cash Equivalents	2.89	5.24	20.24	18.01	9.37	16.68
Ending Cash & Cash Equivalents	10.33	19.57	5.24	20.24	18.01	9.37
Free Cash Flow	7.24	7	-6.97	1.1	4.11	-4.96
Free Cash Flow Growth	3.47%	-	-	-73.26%	-	-
FCF Margin	12.73%	12.29%	-13.90%	2.04%	8.38%	-12.09%
Free Cash Flow Per Share	0.00	0.49	-0.51	0.08	0.29	-0.34
Levered Free Cash Flow	5.63	6.62	-8.22	-3.03	4.95	-3.84
Unlevered Free Cash Flow	5.87	6.62	-8.16	-3.01	4.97	-3.73

Updated Jul 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q